Becton, Dickinson and (BDX) Stock Forecast & Price Target

BDX$209.19—
Medical - Instruments & SuppliesLarge Cap
Compare
Market cap$57.96BEnterprise value—Revenue (TTM)$20.22BMarket positionTop 25%

Score

44
Bearish
Value
43
Quality
49
Growth
39

Becton, Dickinson and Company price target

BDX
Low$159.00
Median$180.00
High$210.00
Upside vs current price-14.0%

The median target of $180.00 is -14.0% versus the current BDX price of $209.19.

Becton, Dickinson and Company analyst ratings

RatingAnalysts
Strong buy1
Buy7
Hold7
Sell0
Strong sell1
ConsensusHold

16 analysts cover BDX.

Becton, Dickinson and Company EPS and revenue estimates

BDX shows the next fiscal years with at least three analysts: 2027 EPS $13.25, 2028 EPS $14.16. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2027$13.25$19.69B
2028$14.16$20.46B

Is Becton, Dickinson and Company a buy or sell?

Of the 16 analysts covering Becton, Dickinson and Company, 8 rate it a buy (1 strong buy and 7 buy), 7 rate it a hold, and 1 rates it a sell (0 sell and 1 strong sell).

The BDX consensus label is Hold, beside 8 buy-side ratings and 1 sell-side ratings.

The median target of $180.00 implies -14.0% versus the current price of $209.19.

Those 16 ratings on BDX are a headcount, and the label on file is Hold.

Reading the Becton, Dickinson and Company forecast

The BDX target band runs from $159.00 to $210.00. The median target inside that band is $180.00.

Set next to the $209.19 BDX quote, that median is -14.0%.

The BDX ratings are split: 8 of 16 analysts are on the buy side, 7 are at hold, and 1 is on the sell side, and the published consensus is Hold.

The BDX EPS path from 2027 ($13.25) to 2028 ($14.16) is rising.

9 firms published targets on BDX, so one note does not swing the median by itself.

Becton, Dickinson and Company forecast questions

What is the BDX price target?

The published range for BDX is $159.00 to $210.00, with a median target of $180.00. That median is -14.0% versus the current price of $209.19.

Is Becton, Dickinson and Company a buy or sell?

Of the 16 analysts covering Becton, Dickinson and Company, 8 rate it a buy, 7 rate it a hold, and 1 rates it a sell. The consensus is Hold, and the BDX headcount is 8 buy, 7 hold, and 1 sell.

What is the EPS estimate for Becton, Dickinson and Company?

Analyst EPS estimates for Becton, Dickinson and Company: 2027 $13.25, 2028 $14.16.

What is the revenue estimate for Becton, Dickinson and Company?

Analyst revenue estimates for Becton, Dickinson and Company: 2027 $19.69B, 2028 $20.46B.

How many analysts cover BDX?

16 analysts cover BDX. Their consensus on BDX is Hold, across those 16.

BDX price $209.19 —

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener